The poor immunosuppressive ability and the enhanced inflammatory function of CD11b+ Ly6Chigh M-MDSCs likely contribute to the accelerated alloskin and tumor graft rejection in mTOR KO recipients. This evidence concerns the gene ITGAM and neoplasm.